Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Amicus Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 293
- +35 vs. Q2 2024
- Shares held
- 310.0M
- +19.1M (+6.6%) vs. Q2 2024
- Total value
- $3.31B
- +$425.5M (+14.7%) vs. Q2 2024
- New holders
- 60
- 90 more added
- Sold out
- 25
- 93 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $11.5K |
| Q1 2026 | 298 | $4.81B |
| Q4 2025 | 332 | $4.57B |
| Q3 2025 | 287 | $2.46B |
| Q2 2025 | 272 | $1.83B |
| Q1 2025 | 286 | $2.55B |
| Q4 2024 | 290 | $2.88B |
| Q3 2024 | 293 | $3.31B |
| Q2 2024 | 259 | $3.13B |
| Q1 2024 | 254 | $3.79B |
| Q4 2023 | 229 | $4.53B |
| Q3 2023 | 229 | $3.63B |
| Q2 2023 | 216 | $3.86B |
| Q1 2023 | 226 | $3.30B |
| Q4 2022 | 230 | $3.57B |
| Q3 2022 | 222 | $3.05B |
| Q2 2022 | 213 | $3.28B |
| Q1 2022 | 216 | $2.87B |
| Q4 2021 | 224 | $3.48B |
| Q3 2021 | 238 | $2.80B |
| Q2 2021 | 235 | $2.67B |
| Q1 2021 | 259 | $2.74B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caption Management, LLC | 0 | $0 | 0.00% | −21,900−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −19,099−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −18,575−100.0% | Sold out |
| Park Avenue Securities LLC | 0 | $0 | 0.00% | −14,513−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −13,445−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −11,431−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −11,297−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −10,252−100.0% | Sold out |
| Fulton Bank, N.A. | 0 | $0 | 0.00% | −10,257−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −2,597−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −1,183−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −593−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −585−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −380−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −189−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |